- Home
- CMPX vs CCIR Comparison
CMPX vs CCIR Comparison
Compare CMPX & CCIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CMPX
- CCIR
- Stock Information
- Founded
- CMPX 2014
- CCIR 2021
- Country
- CMPX United States
- CCIR United States
- Employees
- CMPX N/A
- CCIR N/A
- Industry
- CMPX Biotechnology: Pharmaceutical Preparations
- CCIR
- Sector
- CMPX Health Care
- CCIR
- Exchange
- CMPX Nasdaq
- CCIR NYSE
- Market Cap
- CMPX 408.6M
- CCIR 351.0M
- IPO Year
- CMPX N/A
- CCIR 2024
- Fundamental
- Price
- CMPX $1.95
- CCIR $11.21
- Analyst Decision
- CMPX Strong Buy
- CCIR
- Analyst Count
- CMPX 7
- CCIR 0
- Target Price
- CMPX $12.43
- CCIR N/A
- AVG Volume (30 Days)
- CMPX 850.8K
- CCIR 501.7K
- Earning Date
- CMPX 05-12-2025
- CCIR 01-01-0001
- Dividend Yield
- CMPX N/A
- CCIR N/A
- EPS Growth
- CMPX N/A
- CCIR N/A
- EPS
- CMPX N/A
- CCIR 0.16
- Revenue
- CMPX $850,000.00
- CCIR N/A
- Revenue This Year
- CMPX $47.65
- CCIR N/A
- Revenue Next Year
- CMPX $3,909.48
- CCIR N/A
- P/E Ratio
- CMPX N/A
- CCIR $72.33
- Revenue Growth
- CMPX N/A
- CCIR N/A
- 52 Week Low
- CMPX $0.77
- CCIR $9.92
- 52 Week High
- CMPX $4.08
- CCIR $12.80
- Technical
- Relative Strength Index (RSI)
- CMPX 31.88
- CCIR N/A
- Support Level
- CMPX $2.18
- CCIR N/A
- Resistance Level
- CMPX $2.17
- CCIR N/A
- Average True Range (ATR)
- CMPX 0.16
- CCIR 0.00
- MACD
- CMPX -0.03
- CCIR 0.00
- Stochastic Oscillator
- CMPX 14.60
- CCIR 0.00
About CMPX Compass Therapeutics Inc.
Compass Therapeutics Inc is a clinical-stage biopharmaceutical company that develops proprietary antibody therapeutics intended to engage the immune system to treat both solid tumors and hematological malignancies. It is engaged in drug discovery by leveraging its proprietary antibody discovery engine to broadly drug the immune system and identify optimal combinations empirically. Through StitchMabs and common light chain platforms, these combinatorial insights can be rapidly translated into tailored bispecifics with monoclonal-like manufacturability. Its pipeline is comprised of three product candidates, CTX-009, CTX-471, and CTX-8371.
About CCIR COHEN CIRCLE ACQUISITION CORP I
Cohen Circle Acquisition Corp I is a blank check company.